<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">347606</id>
  <title nil="true"/>
  <common-name>2-[[5-(4-chlorophenyl)-4-(4-methylphenyl)-1,2,4-triazol-3-yl]sulfanyl]-n-[(e)-(2-hydroxynaphthalen-1-yl)methylideneamino]acetamide</common-name>
  <description>2-[[5-(4-chlorophenyl)-4-(4-methylphenyl)-1,2,4-triazol-3-yl]sulfanyl]-n-[(e)-(2-hydroxynaphthalen-1-yl)methylideneamino]acetamide is a chemical compound with the formula C28H22ClN5O2S. With an average molecular weight of 528.00 g/mol, 2-[[5-(4-chlorophenyl)-4-(4-methylphenyl)-1,2,4-triazol-3-yl]sulfanyl]-n-[(e)-(2-hydroxynaphthalen-1-yl)methylideneamino]acetamide is a heavy molecule.</description>
  <cas>303105-50-2</cas>
  <pubchem-id>135810900</pubchem-id>
  <chemical-formula>C28H22ClN5O2S</chemical-formula>
  <weight>528</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-31T11:23:30Z</created-at>
  <updated-at type="dateTime">2026-08-31T11:23:30Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>CC1=CC=C(C=C1)N2C(=NN=C2SCC(=O)NN=CC3=C(C=CC4=CC=CC=C43)O)C5=CC=C(C=C5)Cl</moldb-smiles>
  <moldb-formula>C28H22ClN5O2S</moldb-formula>
  <moldb-inchi>InChI=1S/C28H22ClN5O2S/c1-18-6-13-22(14-7-18)34-27(20-8-11-21(29)12-9-20)32-33-28(34)37-17-26(36)31-30-16-24-23-5-3-2-4-19(23)10-15-25(24)35/h2-16,35H,17H2,1H3,(H,31,36)/b30-16+</moldb-inchi>
  <moldb-inchikey>XVZKVHZLBQEPSW-OKCVXOCRSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">527.1182738</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>6.5</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM343499</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>2-[[5-(4-chlorophenyl)-4-(4-methylphenyl)-1,2,4-triazol-3-yl]sulfanyl]-n-[(e)-(2-hydroxynaphthalen-1-yl)methylideneamino]acetamide</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom nil="true"/>
  <superklass nil="true"/>
  <klass nil="true"/>
  <subklass nil="true"/>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0297945</sync-id>
  <structure-inchikey>XVZKVHZLBQEPSW-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>84000200000800000000800000000000000000000100080005000000000000000000002000004028000002080000000000040000000000000200000000000000000400000000000000000000020000008000200000004000010000000000000010080000000000080000000800000080100000000000000000000000000000040020001800080000000000080880000010100000000000000000000000000000200000000040000080000000000000000400000100000002c00000000000000044000002100000000000000000010000000002000000200000000000000000140000001001048000000000480000000010000000040000000000000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAlAAAAKQAAAIABBgBgAAAAAQMGQCgAAAAD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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:46:09Z</structure-indexed-at>
</compound>
